Table 2.
Baseline predictors for the mean reduction (improvement) of central macular thickness.
| Variable | β | Wald Chi-Square | P-value |
|---|---|---|---|
| Sex | |||
| Female | -0.068 | 0.465 | 0.495 |
| Male (ref.) | − | ||
| Age | 0.006 | 2.053 | 0.152 |
| Diffuse retinal thickening | |||
| 3-6mm | 0.104 | 0.756 | 0.384 |
| 1-3mm | 0.149 | 1.864 | 0.172 |
| ≤1mm | -0.108 | 3.542 | 0.060 |
| 0mm (ref.) | − | ||
| ONL cyst size | |||
| Giant | 0.069 | 1.080 | 0.299 |
| Large | 0.035 | 0.381 | 0.537 |
| Small | -0.165 | 1.908 | 0.167 |
| No (ref.) | − | ||
| IS-OS continuity | |||
| Completely disrupted | -0.396 | 2.034 | 0.154 |
| Partially continuous | -0.138 | 16.392 | <0.001 |
| Completely continuous (ref.) | − | ||
| HRF foci-quantity | |||
| Many (≥11) & all layers | 0.102 | 1.130 | 0.288 |
| Many (≥11) & OPL-ELM | -0.076 | 0.037 | 0.847 |
| Many (≥11) & ILM-INL | 0.013 | 0.037 | 0.848 |
| Few (2-10) & all layers | 0.140 | 2.062 | 0.151 |
| Few (2-10) & OPL-ELM | 0.227 | 0.348 | 0.555 |
| Few (2-10) & ILM-INL | 0.072 | 1.666 | 0.197 |
| Absent (ref.) | − | ||
| Vitreomacular interface | |||
| VMT | 0.259 | 5.938 | 0.015 |
| VMA | 0.083 | 0.845 | 0.358 |
| PVD (ref.) | − | ||
| ERM | |||
| Yes | 0.215 | 5.921 | 0.015 |
| No (ref.) | − | ||
| DR type | |||
| PDR | -0.216 | 1.631 | 0.202 |
| Severe NPDR | -0.121 | 0.555 | 0.456 |
| Moderate NPDR (ref.) | − | ||
| SRD | |||
| Yes | 0.010 | 0.005 | 0.945 |
| No (ref.) | − | ||
ELM, external limiting membrane; ERM, epiretinal membrane; ref, reference; HRF, hyperreflective foci; ILM, internal limiting membrane; IS-OS, inner segment-outer segment; NPDR, non- proliferative diabetic retinopathy; ONL, outer nuclear layer; OPL, outer plexiform layer; PDR, proliferative diabetic retinopathy; PVD, posterior vitreous detachment; SRD, serous retinal detachment; VMA, vitreomacular adhesion; VMT, vitreomacular traction; β, beta coefficient.